[Metabolic markers of bone and clinical use].
Miki
Takami
T
Department of Geriatric Medicine, Graduate School of Medicine, Osaka City University Medical School.
Naka
Hiroshi
H
D000135:Acid Phosphatase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D000596:Amino Acids / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D001851:Bone Diseases, Metabolic / Q000175:diagnosis* / Q000378:metabolism; D001842:Bone and Bones / Q000378:metabolism*; D024042:Collagen Type I / Q000032:analysis; D006801:Humans; D007527:Isoenzymes / Q000032:analysis; D015675:Osteocalcin / Q000032:analysis; D010024:Osteoporosis / Q000175:diagnosis / Q000378:metabolism; D010446:Peptide Fragments / Q000032:analysis; D010455:Peptides / Q000032:analysis; D011347:Procollagen / Q000032:analysis; D000071681:Tartrate-Resistant Acid Phosphatase
D000596:Amino Acids; D015415:Biomarkers; D024042:Collagen Type I; D007527:Isoenzymes; D010446:Peptide Fragments; D010455:Peptides; D011347:Procollagen; C052929:collagen type I trimeric cross-linked peptide; C047202:procollagen Type I N-terminal peptide; C042813:procollagen type I carboxy terminal peptide; D015675:Osteocalcin; C036020:deoxypyridinoline; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase